学术周报 · IF≥10
眼科领域文献阅读汇编
2026年第42周 (2026-10-17) | PubMed (NLM) · DeepSeek 中英双语
数据来源: PubMed E-utilities · 影响因子筛选≥10 · 完整摘要不截断
数据来源: PubMed E-utilities · 影响因子筛选≥10 · 完整摘要不截断
★本周 Top 10 高影响力文献
Ŧ期刊分布统计
| 期刊 | 篇数 | IF |
|---|---|---|
| IEEE transactions on medical imaging | 2 | IF 12.4 |
| JAMA ophthalmology | 1 | IF 10.5 |
| Carbohydrate polymers | 1 | IF 13.2 |
| Water research | 1 | IF 12.8 |
| Ophthalmology | 1 | IF 10.9 |
| Chemical Society reviews | 1 | IF 48.3 |
| Progress in retinal and eye research | 1 | IF 16.2 |
| Materials horizons | 1 | IF 11.4 |
| Journal of sport and health science | 1 | IF 13.1 |
1视网膜疾病 (3篇)
临床研究 (1篇)
The association between physical activity (PA) and ophthalmic disease remains uncertain, as most studies relied on self-report. This study aimed to evaluate the associations between long-term, objectively measured PA by wearable devices (Fitbit) and the incidence and prevalence of common ophthalmic diseases in the All of Us Research Program. We conducted cross-sectional and longitudinal analyses of 14,757 adults with electronic health record (EHR) and Fitbit data. Participants had at least 6 months of valid Fitbit wear (≥10 h/day and ≥100 steps/day). The cohort had a mean age of 55.0 ± 15.7 years (mean ± SD); 70.4% were female, and 79.1% were White. Mean daily step counts and minutes of moderate-to-vigorous physical activity (MVPA) were evaluated in relation to age-related macular degeneration (AMD), diabetic retinopathy (DR), primary open-angle glaucoma (POAG), and senile cataract identified using International Classification of Diseases codes. Logistic regression estimated odds ratios (ORs) for prevalent disease, and Cox proportional hazards models estimated hazard ratios (HRs) for incident disease. Models were adjusted for age, sex, race, and body mass index. DR analyses were also restricted to participants with diabetes mellitus. In cross-sectional analyses, higher PA was significantly associated with lower odds of DR among participants with DM (steps per 1000: OR = 0.91, 95% confident interval (95%CI): 0.86-0.95; p < 0.001; MVPA per 10 min: OR = 0.87, 95%CI: 0.82-0.93; p < 0.001). No significant cross-sectional associations were observed between PA and AMD, POAG, or senile cataract. In longitudinal analyses, higher PA predicted a lower risk of incident DR among participants with DM (steps: HR = 0.93, 95%CI: 0.87-0.99; p = 0.022; MVPA: HR = 0.86, 95%CI: 0.79-0.93; p < 0.001). No significant longitudinal associations were found between PA and AMD, POAG, or senile cataract. Our findings suggest a strong inverse association between sustained PA and incident DR and underscore the value of long-term wearable data for ophthalmic research.
中文摘要:体力活动(PA)与眼科疾病之间的关联仍不确定,因为多数研究依赖自我报告。本研究旨在评估 All of Us Research Program 中由可穿戴设备(Fitbit)长期客观测量的 PA 与常见眼科疾病发病率和患病率之间的关联。我们对 14,757 名同时具有电子健康记录(EHR)和 Fitbit 数据的成年人进行了横断面和纵向分析。参与者至少有 6 个月的有效 Fitbit 佩戴数据(每天至少 10 小时且至少 100 步)。队列平均年龄 55.0 ± 15.7 岁(均值 ± 标准差);70.4% 为女性,79.1% 为白人。评估日均步数和中等至剧烈体力活动(MVPA)分钟数与年龄相关性黄斑变性(AMD)、糖尿病视网膜病变(DR)、原发性开角型青光眼(POAG)和老年性白内障的关系,这些疾病通过国际疾病分类编码识别。Logistic 回归估计患病疾病的比值比(OR),Cox 比例风险模型估计发病疾病的风险比(HR)。模型调整了年龄、性别、种族和体重指数。DR 分析还限制在糖尿病患者中。横断面分析中,较高的 PA 与糖尿病患者中较低的 DR 患病比值显著相关(每 1000 步:OR = 0.91,95% 置信区间(95%CI):0.86-0.95;p < 0.001;每 10 分钟 MVPA:OR = 0.87,95%CI:0.82-0.93;p < 0.001)。PA 与 AMD、POAG 或老年性白内障之间未观察到显著的横断面关联。纵向分析中,较高的 PA 预测糖尿病患者中较低的 DR 发病风险(步数:HR = 0.93,95%CI:0.87-0.99;p = 0.022;MVPA:HR = 0.86,95%CI:0.79-0.93;p < 0.001)。PA 与 AMD、POAG 或老年性白内障之间未发现显著的纵向关联。研究结果提示持续 PA 与 DR 发病之间存在较强的负相关,并强调长期可穿戴数据在眼科研究中的价值。
基础研究 (2篇)
Lime neutralization is widely used to treat acid mine drainage (AMD), yet its long-term efficacy is often undermined by subsequent reacidification. A full-scale field study reveals the transformation of metastable aluminum (Al) minerals. This transformation acts as the key geochemical switch that governs this reversibility. During neutralization, Al precipitates as poorly crystalline hydroxysulfates, efficiently sequestering heavy metals via coprecipitation. However, when treatment stops, these metastable Al phases dissolve preferentially as reacidification begins. During reacidification, Al is released at 92.06 mg/(m²·d). This flux far exceeds that of all other measured metals, and Al accounts for more than 50% of the regenerated acidity. This dissolution converts Al from a primary metal sink into the dominant source of both metals and acidity. Our findings reveal that the stability of Al-bearing phases dictates the long-term success of AMD remediation, not short-term metal removal efficiency. We therefore argue for a paradigm shift toward strategies that ensure the formation of stable mineral phases to achieve sustainable AMD management.
中文摘要:石灰中和广泛用于处理酸性矿山废水(AMD),但其长期效果常因后续再酸化而受损。一项全尺寸现场研究揭示了亚稳态铝矿物的转化过程。这一转化是控制再酸化可逆性的关键地球化学开关。中和过程中,铝以结晶度低的羟基硫酸盐形式沉淀,通过共沉淀有效固定重金属。处理停止后,随着再酸化开始,这些亚稳态铝相优先溶解。再酸化期间,铝的释放通量为92.06 mg/(m²·d)。该通量远高于所有其他被测金属,铝占再生酸度的50%以上。这一溶解过程使铝从主要的金属汇转变为金属和酸度的主要来源。研究结果表明,决定AMD修复长期成效的是含铝相的稳定性,而非短期金属去除效率。因此,我们主张转向确保形成稳定矿物相的策略,以实现可持续的AMD管理。
Age-related macular degeneration (AMD) is a prevalent cause of irreversible vision loss in the elderly worldwide. Current standard treatment relies on repeated intravitreal injection of anti-vascular endothelial growth factor A (anti-VEGFA), which is associated with invasiveness, poor patient compliance, and variable therapeutic responses. To address this, we developed an ocular-penetrating carrier for topical anti-VEGFA delivery by conjugating eicosapentaenoic acid (EPA) to chitosan (CS), yielding EPA-functionalized chitosan (CS-EPA). Interestingly, CS-EPA retains the antioxidant and anti-inflammatory activities of EPA while enhancing ocular penetration by promoting E-cad redistribution and transient tight-junction modulation. It self-assembles with therapeutic proteins through electrostatic interactions, forming stable nanocomplexes, which can efficiently reach the posterior segment of mice after non-invasive eye drop administration. More importantly, in a laser-induced choroidal neovascularization (CNV) mouse model, CS-EPA/anti-VEGFA eye drops inhibited neovascularization as effectively as intravitreal anti-VEGFA injection. Beyond VEGFA neutralization, CS-EPA directly suppressed the nuclear factor-κB (NF-κB) pathway, reduced pro-inflammatory cytokine production, and alleviated oxidative stress, thereby disrupting the inflammation-angiogenesis cycle driving AMD progression. Therefore, the dual-action CS-EPA, with enhanced ocular penetration and intrinsic anti-inflammatory activity, provides a noninvasive, patient-compliant alternative for AMD treatment and holds promise for treating other posterior segment diseases.
中文摘要:年龄相关性黄斑变性(AMD)是全球老年人不可逆视力丧失的常见原因。当前标准治疗依赖反复玻璃体内注射抗血管内皮生长因子A(抗VEGFA),存在侵入性、患者依从性差和疗效反应不一的问题。为此,我们将二十碳五烯酸(EPA)偶联到壳聚糖(CS)上,制备EPA功能化壳聚糖(CS-EPA),构建用于局部递送抗VEGFA的眼部穿透载体。CS-EPA保留了EPA的抗氧化和抗炎活性,同时通过促进E-cad重新分布和短暂调节紧密连接增强眼部穿透。它通过静电作用与治疗性蛋白自组装形成稳定纳米复合物,经无创滴眼给药后可高效到达小鼠眼后段。在激光诱导脉络膜新生血管(CNV)小鼠模型中,CS-EPA/抗VEGFA滴眼液抑制新生血管的效果与玻璃体内注射抗VEGFA相当。除中和VEGFA外,CS-EPA直接抑制核因子κB(NF-κB)通路,减少促炎细胞因子产生,缓解氧化应激,从而打断驱动AMD进展的炎症-血管生成循环。因此,兼具增强眼部穿透和内在抗炎活性的双作用CS-EPA为AMD治疗提供了无创、依从性更好的替代方案,并有望用于其他眼后段疾病。
2小儿眼科与斜视 (2篇)
基础研究 (2篇)
The inherent limitations of conventional dosage forms, particularly for ocular and nasal administration, necessitate advanced drug delivery systems. In situ gelling systems and cyclodextrins (CDs) individually offer significant advantages, while their combination provides a synergistic platform. CD-based in situ gels combine the inclusion complexation ability of CDs with the sol-gel transition properties of stimuli-responsive polymers, enhancing the solubility, stability, and residence time of poorly soluble drugs across various mucosal routes. CDs improve drug availability and protect labile molecules, whereas in situ gels prolong retention and enable sustained release at the application site. Current formulation strategies include the integration of free CDs, drug/CD inclusion complexes, and CD-conjugated polymer networks, each exerting distinct effects on gelation behavior, drug loading, release, and permeation. However, system complexity introduces challenges in formulation optimization, drug-release control, and safety assessment. This review highlights the formulation strategies and pharmaceutical applications of CD-based in situ gels, with particular emphasis on the interplay among CD incorporation, polymer design, gelation mechanisms, drug-release behavior, therapeutic benefits, and inherent limitations across different delivery routes. Finally, the key challenges and future perspectives for translating these systems into clinically applicable formulations are discussed.
中文摘要:传统剂型的固有局限,尤其眼部和鼻部给药,需要先进的药物递送系统。原位凝胶系统与环糊精(CDs)各自具有显著优势,二者结合可提供协同平台。基于CD的原位凝胶将CD的包合能力与刺激响应性聚合物的溶胶-凝胶转变特性结合,提高难溶性药物在多种黏膜途径中的溶解度、稳定性和滞留时间。CDs改善药物可利用性并保护不稳定分子,原位凝胶延长滞留并实现给药部位缓释。现有制剂策略包括游离CDs、药物/CD包合物及CD偶联聚合物网络的整合,各自对凝胶化行为、载药、释放和渗透产生不同影响。但系统复杂性给制剂优化、药物释放控制及安全性评价带来挑战。本综述聚焦基于CD的原位凝胶的制剂策略与药学应用,重点讨论CD引入、聚合物设计、凝胶化机制、药物释放行为、治疗收益及不同给药途径中的固有局限之间的相互作用。最后讨论将这些系统转化为临床可用制剂的关键挑战与未来前景。
Under the broader concept of magnetic induction (MI), in which magnetic fields are used to induce a current in conductors, magnetic induction heating (MIH) is known in oncotherapy for tumour ablation in what is called magnetic hyperthermia. However, a multitude of wider applications of MIH are beginning to shape opportunities at the interface of materials fabrication. This includes organic and inorganic synthesis, a comprehensive spectrum of biomedical needs, sensing, diagnostics, industrial processing, sustainable technologies, power generation and locomotion. A comparative analysis of reported MI studies is given grouped by application type, providing insight into the different materials employed and temperatures achieved. While MIH is predominantly based on magnetic materials that dissipate energy through hysteresis and Néel/Brownian relaxation losses, electrically conductive materials can also generate heat via eddy-current-induced Joule heating, although they remain relatively underexplored in biomedical applications. We examine the field parameters, the set-ups used and experimental configurations to provide a clear overview of the current landscape. In chemistry these applications will interest researchers in areas such as materials synthesis, electrocatalysis and sustainable chemistry. In the biomedical landscape, we explore studies from neuropathology to endometriosis and ocular disease, and even dental applications. Thus, we enable both specialists and researchers from adjacent fields to contribute with fresh perspectives. This review examines MIH through a new lens, highlighting underrepresented and recent developments and identifying promising directions to accelerate progress across different areas of science.
中文摘要:在磁感应(MI)这一更宽泛概念下,磁场用于在导体中诱发电流;磁感应加热(MIH)在肿瘤治疗中以磁热疗实现肿瘤消融而为人所知。MIH 的更多应用正在材料制造交界处形成机会,涉及有机与无机合成、广泛的生物医学需求、传感、诊断、工业加工、可持续技术、发电与驱动。按应用类型对已报道的 MI 研究作比较分析,可了解所用材料与达到温度的差异。MIH 主要依赖通过磁滞以及 Néel/Brownian 弛豫损耗耗散能量的磁性材料,导电材料也可通过涡流诱导的焦耳热产热,但其在生物医学应用中的探索仍相对不足。文章考察场参数、所用装置与实验配置,给出当前图景的清晰概览。在化学领域,这些应用将引起材料合成、电催化与可持续化学研究者的兴趣。在生物医学领域,文章梳理从神经病理学到子宫内膜异位症、眼部疾病乃至牙科应用的研究。由此,专业人员和相邻领域研究者可凭新视角作出贡献。该综述以新视角审视 MIH,突出关注不足与近期进展,并指出有望加速不同科学领域进展的方向。
3影像与人工智能 (2篇)
基础研究 (2篇)
The exponential growth of large vision-language models (VLMs) has created significant opportunities for advancing multimodal artificial intelligence in specialized domains such as ophthalmology. However, progress in ophthalmic VLMs remains limited, primarily due to the lack of large-scale, high-quality image-text pairs. Moreover, existing VLMs frequently generate hallucinations, leading to uncertainty and unreliability that are unacceptable in clinical practice. To address the data scarcity issue, we introduce IT-Retinal, a dedicated ophthalmic Vision Question Answering (VQA) dataset that providesmultigranularity tasks and high-quality long-form textual content in image-text pairs. To mitigate hallucinations, we propose EyeGraph, a framework for ophthalmic VLMs that consists of two training stages, targeted pre-training and fine-tuning, and one inference stage that integrates Graph of Thought (GoT) and Think on Graph (ToG) reasoning, referred to as G2T. This design enables EyeGraph to incorporate structured external knowledge, constrain the output space, and produce more clinically consistent results. Extensive experiments demonstrate that EyeGraph achieves state-of-the-art performance across seven clinically relevant benchmarks, spanning disease diagnosis, structural detection and localization, and report generation. Notably, the proposed G2T reasoning module consistently improves the factual consistency and reliability of ophthalmic report generation. All source code, along with an interactive demo, is publicly available at: https://github.com/ZardCAI/EyeGraph.
中文摘要:大型视觉语言模型的指数级增长为眼科等专科领域的多模态人工智能发展带来了重要机遇。然而,眼科视觉语言模型的进展仍然有限,主要原因在于缺乏大规模高质量图像-文本配对。现有视觉语言模型还经常产生幻觉,带来临床实践中不可接受的不确定性和不可靠性。为解决数据稀缺问题,我们提出 IT-Retinal,一个专门的眼科视觉问答数据集,在图像-文本配对中提供多粒度任务和高质量长文本内容。为减轻幻觉,我们提出 EyeGraph,一个面向眼科视觉语言模型的框架,包含两个训练阶段——定向预训练和微调,以及一个整合思维图(Graph of Thought, GoT)与图思维(Think on Graph, ToG)推理的推理阶段,合称 G2T。该设计使 EyeGraph 能够引入结构化外部知识、约束输出空间并产生更符合临床的结果。大量实验表明,EyeGraph 在七个临床相关基准上取得了最先进性能,涵盖疾病诊断、结构检测与定位以及报告生成。所提出的 G2T 推理模块持续提升眼科报告生成的事实一致性和可靠性。所有源代码及交互式演示已公开于:https://github.com/ZardCAI/EyeGraph。
Posterior subcapsular cataract (PSC) is a leading cause of blindness and vision impairment globally. Precise PSC grading is critical for immediate treatment and opacity progression observation. Recent studies have suggested the great potential of anterior segment optical coherence tomography (AS-OCT) images in objectively investigating the opacities of PSC compared to conventional slit-lamp examinations with clinical features such as average and maximum. However, the irregular morphology and diffuse distribution modeling of its opacities in AS-OCT images present two significant challenges for precise PSC grading, which have not been addressed previously. To address these challenges, we propose a novel Style-Prior Enhanced-and-Selective State Space Model (SPES-SSM), which effectively captures the irregular morphology and diffuse opacity distribution representations by leveraging the potential of SSM and multi-scale convolution concurrently; and then employs the well-designed style-prior enhanced-and-selective representation block to estimate the relative significances of these two representation types via useful clinical feature (e.g., average and maximum) prior exploration of PSC. By stacking SPES-SSM modules, we construct SPES-Mamba for automated PSC grading based on AS-OCT images. To enhance our SPES-Mamba's reliability and further improve its PSC grading results, we design a class-oriented contrastive learning (COCL), which explores the potential of the ranking matrix of label distance from the aspect of class-averaging. Extensive experiments demonstrate that SPES-Mamba and COCL significantly outperform state-of-the-art methods in terms of PSC grading results and reliability.
中文摘要:后囊下白内障(PSC)是全球致盲和视力损害的主要原因之一。精确的PSC分级对及时治疗和观察混浊进展至关重要。近期研究表明,与依赖平均、最大值等临床特征的传统裂隙灯检查相比,眼前节光学相干断层扫描(AS-OCT)图像在客观研究PSC混浊方面具有较大潜力。但AS-OCT图像中混浊形态不规则且呈弥漫分布,其建模给精确PSC分级带来两个此前未解决的显著挑战。为应对这些挑战,提出一种新的风格先验增强与选择性状态空间模型(SPES-SSM),同时利用SSM和多尺度卷积的潜力,有效捕获不规则形态与弥漫混浊分布表征;随后采用设计好的风格先验增强与选择性表征模块,通过探索PSC有用的临床特征先验(如平均值和最大值)来估计这两类表征的相对重要性。堆叠SPES-SSM模块构建SPES-Mamba,用于基于AS-OCT图像的自动PSC分级。为提升SPES-Mamba的可靠性并进一步改善PSC分级结果,设计面向类别的对比学习(COCL),从类别平均的角度挖掘标签距离排序矩阵的潜力。大量实验显示,SPES-Mamba与COCL在PSC分级结果和可靠性上显著优于当前先进方法。
4眼肿瘤 (1篇)
临床研究 (1篇)
Gene expression profiling (GEP) reliably predicts metastatic uveal melanoma risk and is used to manage uveal melanoma (UM) in patients with this diagnosis. Efforts to refine molecular prognostication continue. To determine if confirmatory cytopathology findings influence the prognostic accuracy of a commercially available GEP/Preferentially Expressed Antigen in Melanoma (PRAME) assay. The Collaborative Ocular Oncology Group 2 study, a prospective cohort study, was conducted from 2017 to 2020 with follow-up recorded at 6-month intervals. This was a multicenter study that included patients with choroidal and/or ciliary body melanoma and results from a 15-GEP and PRAME RNA expression (15-GEP/PRAME) assay. Patients with iris tumors or less than 6 months' follow-up were excluded. Study data were analyzed from April 2025 to July 2026. 15-GEP/PRAME, cytopathology, and next-generation sequencing (NGS). Metastatic uveal melanoma rates in patients who had 15-GEP/PRAME and confirmatory cytopathology (CCP) results confirming or suspicious for UM (GEP+CCP) were compared with those who had 15-GEP/PRAME and no cytopathology performed, or unknown or nondiagnostic cytopathology results (GEP only). UM-associated variants identified by NGS were also evaluated. Of 1537 patients (mean [SD] age, 62.0 [13.4] years; 787 male [51.2%]), 727 (47.3%) had CCP results, and 810 (52.7%) had nondiagnostic cytopathology results or no cytopathology performed. Class 2/PRAME+ tumors were more common (136 of 727 [18.7%]) in the GEP+CCP group than in the GEP-only group (72 of 810 [8.9%]; 9.8% difference; 95% CI, 6.4-13.3; P <.001), whereas class 1/PRAME- tumors were less common (330 of 727 [45.4%] vs 495 of 810 [61.1%]; 15.7% difference; 95% CI, 10.8-20.6; P <.001). In patients with GEP+CCP, 22.7% (n = 165) developed metastasis vs 15.4% (n = 125) in patients with GEP only (7.3% difference, 95% CI, 3.3-11.2; P < .001). Adjusting for 15-GEP/PRAME status, there were no differences in metastasis rates between CCP groups. Of 1327 patients with successful NGS, 94.1% (605 of 643) in the GEP+CCP group and 71.9% (492 of 684) in the GEP-only group had a UM-associated variant (22.2% difference, 95% CI, 18.3-26.0; P < .001). Results of this cohort study reveal that no differences in metastasis outcomes were observed between patients with and without CCP within any GEP/PRAME categories. UM-associated variants were found less frequently in the GEP-only group than in the GEP+CCP group. In this cohort, 15-GEP/PRAME classification without CCP retained prognostic validity, supporting its clinical consideration in guiding metastatic surveillance in cases in which cytopathology is unavailable.
中文摘要:基因表达谱(GEP)可可靠预测葡萄膜黑色素瘤转移风险,并用于该诊断患者的葡萄膜黑色素瘤管理。分子预后判断的改进工作仍在继续。旨在确定验证性细胞病理学结果是否影响市售GEP/黑色素瘤优先表达抗原(PRAME)检测的预后准确性。协作性眼肿瘤学组2研究是一项前瞻性队列研究,于2017年至2020年开展,随访按6个月间隔记录。该多中心研究纳入脉络膜和/或睫状体黑色素瘤患者,并具有15-GEP与PRAME RNA表达(15-GEP/PRAME)检测结果。虹膜肿瘤患者或随访不足6个月者被排除。研究数据于2025年4月至2026年7月分析。检测包括15-GEP/PRAME、细胞病理学和下一代测序(NGS)。比较15-GEP/PRAME且有验证性细胞病理学(CCP)结果证实或疑似葡萄膜黑色素瘤(GEP+CCP)患者的葡萄膜黑色素瘤转移率,与有15-GEP/PRAME但未进行细胞病理学检查、或细胞病理学结果未知或不能诊断(仅GEP)者。还评估NGS识别的葡萄膜黑色素瘤相关变异。1537例患者(平均[SD]年龄62.0[13.4]岁;男性787例[51.2%])中,727例(47.3%)有CCP结果,810例(52.7%)细胞病理学结果不能诊断或未进行细胞病理学检查。2类/PRAME+肿瘤在GEP+CCP组更常见(727例中136例[18.7%]),高于仅GEP组(810例中72例[8.9%];差异9.8%;95% CI,6.4-13.3;P<.001),而1类/PRAME-肿瘤较少见(727例中330例[45.4%]对比810例中495例[61.1%];差异15.7%;95% CI,10.8-20.6;P<.001)。GEP+CCP患者中22.7%(n=165)发生转移,仅GEP患者中为15.4%(n=125)(差异7.3%,95% CI,3.3-11.2;P<.001)。校正15-GEP/PRAME状态后,CCP组间转移率无差异。1327例NGS成功的患者中,GEP+CCP组94.1%(643例中605例)和仅GEP组71.9%(684例中492例)存在葡萄膜黑色素瘤相关变异(差异22.2%,95% CI,18.3-26.0;P<.001)。该队列研究结果显示,在任何GEP/PRAME类别内,有和无CCP的患者之间未观察到转移结局差异。仅GEP组中葡萄膜黑色素瘤相关变异检出频率低于GEP+CCP组。在该队列中,无CCP的15-GEP/PRAME分类仍保留预后有效性,支持在细胞病理学不可得的情况下将其纳入临床考虑以指导转移监测。
5青光眼 (1篇)
临床研究 (1篇)
To determine long-term visual and ocular outcomes in a large cohort of patients with choroidal melanoma treated using palladium-103 (103Pd) plaque brachytherapy. This is a retrospective cohort study. 170 patients with a minimum of 10 years of continuous follow-up at The New York Eye Cancer Center following 103Pd plaque brachytherapy treatment for choroidal melanoma. The study includes collected data consisting of patient demographic characteristics, tumor features, such as size, location, and AJCC clinical T-category (cT), visual outcomes, variables related to post-treatment retinopathy management, and long-term ocular comorbidities. The primary endpoints were tumor control, ocular conservation, and visual acuity. Secondary endpoints included long-term radiation-related complications, additional ocular interventions, and associated comorbidities. Statistical analyses were performed using the Kaplan-Meier survival method, t-tests, Wilcoxon rank-sum tests, chi-square tests, and linear regression plots. Among 170 patients with a minimum 10-year follow-up there was 100% local tumor control. One eye (0.6%) was enucleated due to neovascular glaucoma and patient choice. Kaplan-Meier analysis demonstrated visual acuity retention rates of 92.7% at 12 years, 87.0% at 15 years, and 63.7% at 20 years defined as vision of 20/200 or better. Radiation retinopathy was managed with anti-vascular endothelial growth factor (anti-VEGF) therapy, intravitreal corticosteroids, and laser treatment. Tumors located closer to the fovea were associated with increased foveal radiation doses and poorer visual acuity outcomes. Treatment of juxtapapillary and circumpapillary tumors was associated with the highest rates of vision loss. This study is the largest and longest follow-up analysis of 103Pd plaque brachytherapy for choroidal melanoma. It provides new long-term information on tumor control, ocular morbidity, and visual outcomes that are valuable for patient counseling and therapeutic decision-making.
中文摘要:评估接受钯-103(103Pd)敷贴近距离放疗的脉络膜黑色素瘤患者大型队列的长期视力和眼部结局。这是一项回顾性队列研究,纳入170例在纽约眼癌中心接受103Pd敷贴近距离放疗后连续随访至少10年的脉络膜黑色素瘤患者。研究收集的数据包括患者人口学特征、肿瘤特征(如大小、位置和AJCC临床T分期cT)、视力结局、治疗后视网膜病变管理相关变量以及长期眼部合并症。主要终点为肿瘤控制、保眼和视力。次要终点包括长期放疗相关并发症、额外眼部干预和相关合并症。统计分析采用Kaplan-Meier生存法、t检验、Wilcoxon秩和检验、卡方检验和线性回归图。170例随访至少10年的患者中,局部肿瘤控制率为100%。1眼(0.6%)因新生血管性青光眼和患者选择而行眼球摘除。Kaplan-Meier分析显示,以视力20/200或更好为定义,视力保留率在12年为92.7%,15年为87.0%,20年为63.7%。放射性视网膜病变通过抗血管内皮生长因子(anti-VEGF)治疗、玻璃体内糖皮质激素和激光治疗进行管理。更靠近黄斑中心凹的肿瘤与更高的中心凹放射剂量和更差的视力结局相关。邻近视盘和环绕视盘肿瘤的治疗与最高视力丧失率相关。本研究是103Pd敷贴近距离放疗治疗脉络膜黑色素瘤规模最大、随访时间最长的分析,提供了关于肿瘤控制、眼部疾病负担和视力结局的新长期信息,对患者咨询和治疗决策具有价值。
6基因治疗与再生医学 (1篇)
基础研究 (1篇)
The molecular basis for vertebrate color vision is expression of spectrally-selective opsin-based photopigments within distinct cone photoreceptor populations. In several primates including humans, and in numerous fish species, genes encoding duplicated, spectrally-divergent cone opsin proteins may be positioned in tandem arrays. This article reviews studies of the regulation of differential expression of these duplicated cone opsin genes in humans and fish, with an emphasis on knowledge derived from the zebrafish model. In humans, the long wavelength-sensitive/medium wavelength-sensitive (LWS/MWS; red/green) tandemly-duplicated array underlies trichromatic color vision; mutations in this array cause altered color vision and retinal degenerations. A foundational model posited that regulation of human LWS vs. MWS opsin expression is stochastic, whereby an upstream enhancer associates randomly with promoters of the proximal or distal gene, and one of these associations becomes permanent. Discoveries of tandemly-duplicated cone opsin genes in teleost fish, including the versatile zebrafish model, led to their use to further pursue mechanisms of differential expression. The tandemly-duplicated zebrafish lws1 and lws2 genes (encoding red-sensing cone opsins) share a common ancestral gene with human LWS and MWS. Subsequent studies revealed that differential expression of these genes is regulated by the paracrine signal retinoic acid (RA) and the endocrine signal thyroid hormone (TH). Further investigations identified additional cone transcripts distinguishing zebrafish LWS1 vs. LWS2 cones, plasticity of cone opsin expression across the lifespan in response to TH, and a candidate receptor and cis-regulatory element. The findings warrant updates to the foundational model and further consideration of hypotheses for regulation of the human LWS vs. MWS genes.
中文摘要:脊椎动物色觉的分子基础是在不同视锥细胞群体中表达具有光谱选择性的视蛋白光色素。在包括人类在内的若干灵长类以及许多鱼类中,编码复制并光谱分化的视锥视蛋白的基因可呈串联阵列排列。综述人类和鱼类中这些重复视锥视蛋白基因差异表达调控的研究,重点介绍来自斑马鱼模型的认识。在人类中,长波长敏感/中波长敏感(LWS/MWS;红/绿)串联重复阵列构成三色色觉的基础;该阵列突变可导致色觉改变和视网膜变性。一个基础模型提出,人类LWS与MWS视蛋白表达的调控是随机的,上游增强子随机与近端或远端基因的启动子结合,其中一种结合成为永久状态。真骨鱼类(包括多用途的斑马鱼模型)中串联重复视锥视蛋白基因的发现,使这些基因被用于进一步探究差异表达机制。斑马鱼串联重复的lws1和lws2基因(编码红敏感视锥视蛋白)与人类LWS和MWS共享一个共同祖先基因。后续研究显示,这些基因的差异表达受旁分泌信号视黄酸(RA)和内分泌信号甲状腺激素(TH)调控。进一步研究鉴定了区分斑马鱼LWS1与LWS2视锥细胞的额外视锥转录本、视锥视蛋白表达在生命周期中响应TH的可塑性,以及一个候选受体和顺式调控元件。这些发现需要对基础模型进行更新,并进一步考虑人类LWS与MWS基因调控的假说。